More from the WHO:
- says solidarity therapeutics trial produces conclusive evidence on effectiveness of repurposed drugs for covid-19 in record time
- says interim remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon regimens appeared to have little or no effect on 28-day mortality
- who-interim results in trial indicate remdesivir appeared to have little or no effect on 28day mortality or in-hospital course of covid-19 in patients
- study, which spans over 30 countries, looked at effects of treatments on overall mortality, initiation of ventilation, duration of hospital stay
- newer antiviral drugs, immunomodulators and anti-sars cov-2 monoclonal antibodies are now being considered for evaluation at solidarity trial
Headlines via Reuters